Related references
Note: Only part of the references are listed.Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Long-Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: Results up to 8 Years
James Fung et al.
HEPATOLOGY (2017)
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
JOURNAL OF HEPATOLOGY (2017)
Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection
Rogier van Gent et al.
TRANSPLANTATION REVIEWS (2017)
Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis
R. A. A. Ponde
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin
Annapoorani Veerappan et al.
HUMAN IMMUNOLOGY (2016)
EASL Clinical Practice Guidelines: Liver transplantation
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2016)
Liver transplantation for viral hepatitis in 2015
Alberto Ferrarese et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014
Shiv Kumar Sarin et al.
HEPATOLOGY INTERNATIONAL (2014)
Therapy of Acute and Fulminant Hepatitis B
Hans L. Tillmann et al.
INTERVIROLOGY (2014)
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
Peijie Wang et al.
PLOS ONE (2014)
Management of hepatitis B virus-related acute liver failure
Makoto Oketani et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2014)
Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009
Makoto Oketani et al.
HEPATOLOGY RESEARCH (2013)
Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011
William M. Lee et al.
HEPATOLOGY (2012)
Association between S21 substitution in the core protein of hepatitis B virus and fulminant hepatitis
Jun Inoue et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
The option of HBIG-free prophylaxis against recurrent HBV
Alyson N. Fox et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Lamivudine treatment is associated with improved survival in fulminant hepatitis B
Jian-Wu Yu et al.
LIVER INTERNATIONAL (2011)
Control of Hepatitis B Virus Replication by Innate Response of HepaRG Cells
Julie Lucifora et al.
HEPATOLOGY (2010)
Hepatitis B-Associated Acute Liver Failure: Immediate Treatment with Entecavir Inhibits Hepatitis B Virus Replication and Potentially Its Sequelae
Christoph Jochum et al.
DIGESTION (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Case-control study for the identification of virological factors associated with fulminant hepatitis B
Atsunori Kusakabe et al.
HEPATOLOGY RESEARCH (2009)
Fulminant hepatitis and late onset hepatic failure in Japan
Kenji Fujiwara et al.
HEPATOLOGY RESEARCH (2008)
Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors
Alexander J. V. Thompson et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
A randomized controlled trial of lamivudine to treat acute hepatitis B
M. Kumar et al.
HEPATOLOGY (2007)
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
HL Tillmann et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B
M Kumar et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation
J Kwekkeboom et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
A Marzano et al.
LIVER TRANSPLANTATION (2005)
Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States
CT Wai et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Lamivudine treatment for acute severe hepatitis B: a pilot study
H Schmilovitz-Weiss et al.
LIVER INTERNATIONAL (2004)